Literature DB >> 17386182

Role of reactive oxygen species in myocardial remodeling.

Min Zhang1, Ajay M Shah.   

Abstract

Adverse cardiac remodeling is a fundamental process in the progression to chronic heart failure. Although the mechanisms underlying cardiac remodeling are multi-factorial, a significant body of evidence points to the crucial roles of increased reactive oxygen species. This article reviews recent advances in delineating the different sources of production for reactive oxygen species (namely mitochondria, xanthine oxidase, uncoupled nitric oxide synthases, and NADPH oxidases) that may be involved in cardiac remodeling and the aspects of the remodeling process that they affect. These data could suggest new ways of targeting redox pathways for the prevention and treatment of adverse cardiac remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386182     DOI: 10.1007/s11897-007-0022-5

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  44 in total

1.  Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.

Authors:  Roberto M Saraiva; Khalid M Minhas; Shubha V Y Raju; Lili A Barouch; Eleanor Pitz; Karl H Schuleri; Koenraad Vandegaer; Dechun Li; Joshua M Hare
Journal:  Circulation       Date:  2005-11-21       Impact factor: 29.690

2.  Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction.

Authors:  T Fukui; M Yoshiyama; A Hanatani; T Omura; J Yoshikawa; Y Abe
Journal:  Biochem Biophys Res Commun       Date:  2001-03       Impact factor: 3.575

3.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Shuxun Ren; E Rene Rodriguez; Barbara Tavazzi; Giuseppe Lazzarino; Nazareno Paolocci; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

4.  A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.

Authors:  Young M Kim; Tomasz J Guzik; Yin Hua Zhang; Mei Hua Zhang; Hassan Kattach; Chandi Ratnatunga; Ravi Pillai; Keith M Channon; Barbara Casadei
Journal:  Circ Res       Date:  2005-08-25       Impact factor: 17.367

5.  Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Authors:  Hartmut Ruetten; Stefanie Dimmeler; Doris Gehring; Christian Ihling; Andreas M Zeiher
Journal:  Cardiovasc Res       Date:  2005-02-24       Impact factor: 10.787

6.  Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.

Authors:  Shouji Matsushima; Tomomi Ide; Mayumi Yamato; Hidenori Matsusaka; Fumiyuki Hattori; Masaki Ikeuchi; Toru Kubota; Kenji Sunagawa; Yasuhiro Hasegawa; Tatsuya Kurihara; Shinzo Oikawa; Shintaro Kinugawa; Hiroyuki Tsutsui
Journal:  Circulation       Date:  2006-04-03       Impact factor: 29.690

7.  Requirement of Rac1 in the development of cardiac hypertrophy.

Authors:  Minoru Satoh; Hisakazu Ogita; Kyosuke Takeshita; Yasushi Mukai; David J Kwiatkowski; James K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

8.  Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.

Authors:  David J Grieve; Jonathan A Byrne; Anjana Siva; Joanne Layland; Sofian Johar; Alison C Cave; Ajay M Shah
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

9.  Activation of NADPH oxidase during progression of cardiac hypertrophy to failure.

Authors:  Jian-Mei Li; Nick P Gall; David J Grieve; Mingyou Chen; Ajay M Shah
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

10.  Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.

Authors:  Fumito Ichinose; Kenneth D Bloch; Justina C Wu; Ryuji Hataishi; H Thomas Aretz; Michael H Picard; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-11-26       Impact factor: 4.733

View more
  8 in total

1.  Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria.

Authors:  Brian A Stanley; Vidhya Sivakumaran; Sa Shi; Iain McDonald; David Lloyd; Walter H Watson; Miguel A Aon; Nazareno Paolocci
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 2.  The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy.

Authors:  Shin-ichi Oka; Tetsuro Ago; Takanari Kitazono; Daniela Zablocki; Junichi Sadoshima
Journal:  J Mol Med (Berl)       Date:  2009-05-08       Impact factor: 4.599

3.  Cardioprotective role of FA against isoproterenol induced cardiac toxicity.

Authors:  Pankaj G Jain; Umesh B Mahajan; Sachin D Shinde; Sanjay J Surana
Journal:  Mol Biol Rep       Date:  2018-08-13       Impact factor: 2.316

Review 4.  Mitochondrial aldehyde dehydrogenase and cardiac diseases.

Authors:  Che-Hong Chen; Lihan Sun; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2010-06-16       Impact factor: 10.787

5.  Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling.

Authors:  Yu-Fang Jin; Hai-Chao Han; Jamie Berger; Qiuxia Dai; Merry L Lindsey
Journal:  BMC Syst Biol       Date:  2011-05-05

Review 6.  Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.

Authors:  Jacob George; Allan D Struthers
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 7.  Nutritional Deficiency in Patients with Heart Failure.

Authors:  Edoardo Sciatti; Carlo Lombardi; Alice Ravera; Enrico Vizzardi; Ivano Bonadei; Valentina Carubelli; Elio Gorga; Marco Metra
Journal:  Nutrients       Date:  2016-07-22       Impact factor: 5.717

8.  The effects of ginsenoside Rb1 on fatty acid β-oxidation, mediated by AMPK, in the failing heart.

Authors:  Hong-Liang Kong; Ai-Jie Hou; Ning-Ning Liu; Bo-Han Chen; Sheng-Nan Dai; Hua-Ting Huang
Journal:  Iran J Basic Med Sci       Date:  2018-07       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.